Elanco Animal Health Total Long Term Liabilities 2016-2024 | ELAN

Elanco Animal Health total long term liabilities from 2016 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Elanco Animal Health total long term liabilities for the quarter ending September 30, 2024 were $5.439B, a 21.68% decline year-over-year.
  • Elanco Animal Health total long term liabilities for 2023 were $6.898B, a 6.12% increase from 2022.
  • Elanco Animal Health total long term liabilities for 2022 were $6.5B, a 11.24% decline from 2021.
  • Elanco Animal Health total long term liabilities for 2021 were $7.323B, a 2.56% increase from 2020.
Elanco Animal Health Annual Total Long Term Liabilities
(Millions of US $)
2023 $6,898
2022 $6,500
2021 $7,323
2020 $7,140
2019 $2,620
2018 $2,789
2017 $517
2016 $453
2015 $
Elanco Animal Health Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $5,439
2024-06-30 $6,452
2024-03-31 $6,731
2023-12-31 $6,898
2023-09-30 $6,945
2023-06-30 $7,092
2023-03-31 $6,711
2022-12-31 $6,500
2022-09-30 $6,590
2022-06-30 $7,123
2022-03-31 $7,332
2021-12-31 $7,323
2021-09-30 $7,521
2021-06-30 $6,863
2021-03-31 $6,947
2020-12-31 $7,140
2020-09-30 $7,022
2020-06-30 $2,389
2020-03-31 $2,358
2019-12-31 $2,620
2019-09-30 $2,595
2019-06-30 $2,814
2019-03-31 $2,843
2018-12-31 $2,789
2018-09-30 $2,829
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2016-12-31 $453
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $7.054B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
Quest Diagnostics (DGX) United States $17.877B 18.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00